Search details
1.
Long Non-coding RNA Neat1, NLRP3 Inflammasome, and Acute Kidney Injury.
J Am Soc Nephrol
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38687867
2.
Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
Nephrol Dial Transplant
; 38(10): 2232-2247, 2023 09 29.
Article
in English
| MEDLINE | ID: mdl-36914214
3.
Protective role of kallistatin in renal fibrosis via modulation of Wnt/ß-catenin signaling.
Clin Sci (Lond)
; 135(3): 429-446, 2021 02 12.
Article
in English
| MEDLINE | ID: mdl-33458750
4.
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
Clin Sci (Lond)
; 134(21): 2873-2891, 2020 11 13.
Article
in English
| MEDLINE | ID: mdl-33078834
5.
Activated renal tubular Wnt/ß-catenin signaling triggers renal inflammation during overload proteinuria.
Kidney Int
; 93(6): 1367-1383, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29605095
6.
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.
Nephrol Dial Transplant
; 33(8): 1323-1332, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29294056
7.
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.
Kidney Int
; 89(2): 386-98, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26536000
8.
Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells.
Apoptosis
; 20(7): 907-20, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25808596
9.
BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy.
Clin Sci (Lond)
; 128(4): 269-80, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25200314
10.
BMP-7 represses albumin-induced chemokine synthesis in kidney tubular epithelial cells through destabilization of NF-κB-inducing kinase.
Immunol Cell Biol
; 92(5): 427-35, 2014.
Article
in English
| MEDLINE | ID: mdl-24418819
11.
Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms.
Inflamm Res
; 63(10): 831-9, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25063374
12.
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Kidney Int
; 83(5): 887-900, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23423259
13.
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Breast Cancer Res Treat
; 139(2): 381-90, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23712790
14.
Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
J Am Soc Nephrol
; 23(1): 86-102, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22021706
15.
The role of leptin and its short-form receptor in inflammation in db/db mice infused with peritoneal dialysis fluid.
Nephrol Dial Transplant
; 27(8): 3119-29, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22287654
16.
Tubular ß-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury.
Cell Death Dis
; 13(12): 1061, 2022 12 20.
Article
in English
| MEDLINE | ID: mdl-36539406
17.
Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice.
Lab Invest
; 91(9): 1351-62, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21537328
18.
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.
J Transl Med
; 9: 169, 2011 Oct 06.
Article
in English
| MEDLINE | ID: mdl-21974877
19.
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.
Pediatr Nephrol
; 26(2): 257-66, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21125406
20.
Differential effects of advanced glycation end-products on renal tubular cell inflammation.
Nephrology (Carlton)
; 16(4): 417-25, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21143336